Why healthcare startups fail and 5 that bit the dust in 2018
Healthcare VCs provided their thoughts on why startups die, followed by a roundup of five companies that didn't survive 2018.
Is Driver a story of fast fail or a cautionary tale against pursuing DTC model?
Driver reportedly raised around $100 million and had top medical minds on its scientific advisory board, but the $3,000 price tag for its services that its cancer patients would have to pay appears to have been a flawed model to begin with.
Where Will AI Deployment Benefit Payers the Most?
We are taking a look at how health insurers are using AI, defining success, and managing cybersecurity risks. Give us your opinions by completing our brief, anonymous survey.
Report: Cancer clinical trials tech startup Driver shutters two months after launch
The high cost to join the platform - which combined molecular pathology labs with a mobile app - played a role in its low sign-up numbers, CEO says.